10-1 improved recovery after MCAO R in the acute phase, and was associated with increased M2 microglial activation, increased astrocyte NRF2 and GLT-1 expression, and increased Treg cell numbers recruited into the stroke penumbra (Figure 5). The gene discussed is SLC1A2; the disease is Stroke.